Assessing Mind Medicine (MNMD) Valuation After A Strong Year Of Share Price Momentum [Yahoo! Finance]
Mind Medicine (MindMed) (NASDAQ:MNMD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
Wall Street Thinks This 1 Psychedelic Stock Can Gain 335% in 2026 [Yahoo! Finance]
Mind Medicine (MindMed) (NASDAQ:MNMD) is now covered by analysts at Jones Trading. They set a "buy" rating and a $61.00 price target on the stock.
Psychedelics stocks could benefit from marijuana rescheduling: Jefferies [Seeking Alpha]